Latest Form 4 insider transactions

Julian Delany, Chief Technology Officer of News Corp, sold 1,747 shares of common stock on August 15, 2026 for $28.72 per share.

Ruth Allen, Chief Human Resources Officer of News Corp, sold 21,521 shares of common stock on August 15, 2026 for $28.99 per share.

Keith Rupert Murdoch, Chairman Emeritus of News Corp, reported multiple transactions in common stock on August 15, 2026.

Brian H. Nutt, VP, Chief Accounting Officer of Omnicell, Inc., reported a transaction in 937 shares of common stock on August 15, 2026.

Nnamdi Njoku, President & COO of Omnicell, Inc., sold 3,083 shares of common stock on August 15, 2026 for $36.85 per share.

Randall A Lipps, CHAIRMAN, CEO and a Director of Omnicell, Inc., reported a transaction in 12,350 shares of common stock on August 15, 2026.

Jerome Wong, Chief Financial Officer of Ekso Bionics Holdings, Inc., received 300,000 shares of common stock on August 16, 2026.

Corey J Manley, EVP&CHIEF LEGAL/ADMIN OFFICER of Omnicell, Inc., reported a transaction in 4,025 shares of common stock on August 15, 2026.

Kevin Henkin, EVP, Chief Credit Officer of NB Bancorp, Inc., sold 2,000 shares of common stock on August 14, 2026 for $22.93 per share.

Benjamin Stone, Chief Business Officer of First Tracks Biotherapeutics, Inc., received 60,492 shares of common stock on August 15, 2026.

Andrew D Ross, President & COO of Parker Hannifin Corp, sold 5,498 shares of common stock on August 14, 2026 for $1,057.57 per share.

Paul F. Lizzul, Chief Medical Officer of First Tracks Biotherapeutics, Inc., received 60,492 shares of common stock on August 15, 2026.

Daniel Faga, President, CEO and a Director of First Tracks Biotherapeutics, Inc., received 193,575 shares of common stock on August 15, 2026.

Brian N Schell, EVP & CFO of SS&C Technologies Holdings Inc, reported multiple transactions in common stock on August 15, 2026.

Rob Irvin, Chief Financial Officer and a Director of Marex Group plc, sold 3,700 shares of common stock on August 14, 2026.

Neil Glat, a Director of Evolv Technologies Holdings, Inc., purchased 8,500 shares of common stock on August 14, 2026 for $5.74 per share.

Ram Shankar, Chief Financial Officer of Umb Financial Corp, sold 2,000 shares of common stock on August 17, 2026 for $151.61 per share.

Henrik Kuhl, a Director of Evolv Technologies Holdings, Inc., purchased 15,000 shares of common stock on August 14, 2026 for $5.73 per share.

Jan Siegmund, a Director of Marsh & Mclennan Companies, Inc., reported a transaction in 12 shares of common stock on August 14, 2026.

Kenneth B. Robinson, a Director of Paylocity Holding Corp, received 2,207 shares of common stock on August 14, 2026.

Ryan Glenn, Chief Financial Officer of Paylocity Holding Corp, reported multiple transactions in common stock on August 14, 2026.

Melissa Ann King, SVP Product and Technology of Paylocity Holding Corp, reported multiple transactions in common stock on August 14, 2026.

Linda M. Breard, a Director of Paylocity Holding Corp, received 2,207 shares of common stock on August 14, 2026.

Toby J. Williams, President and CEO and a Director of Paylocity Holding Corp, sold 12,000 shares of common stock on August 14, 2026.

Virginia G Breen, a Director of Paylocity Holding Corp, received 2,207 shares of common stock on August 14, 2026.

Timothy Clossey, a Director of Par Pacific Holdings, Inc., sold 13,436 shares of common stock on August 14, 2026.

Joshua Scutt, SVP Chief Revenue Officer of Paylocity Holding Corp, reported multiple transactions in common stock on August 14, 2026.

Nicholas Rost, VP CAO & Treasurer of Paylocity Holding Corp, received 7,981 shares of common stock on August 14, 2026.

William P Scully, a 10% owner of Prothena Corp Public Ltd Co, reported multiple transactions in common stock on August 18, 2026.

Ronald Waters V, a Director of Paylocity Holding Corp, received 2,207 shares of common stock on August 14, 2026.